| Endocytosis, intracellular traffic and fate of cell penetrating peptide based conjugates and nanoparticles K Cleal, L He, P D Watson, A T Jones Current pharmaceutical design 19 (16), 2878-2894, 2013 | 124 | 2013 |
| Telomere length dynamics and the evolution of cancer genome architecture K Cleal, K Norris, D Baird International Journal of Molecular Sciences 19 (2), 482, 2018 | 83 | 2018 |
| Chromothripsis during telomere crisis is independent of NHEJ, and consistent with a replicative origin K Cleal, RE Jones, JW Grimstead, EA Hendrickson, DM Baird Genome research 29 (5), 737-749, 2019 | 54 | 2019 |
| Dysgu: efficient structural variant calling using short or long reads K Cleal, DM Baird Nucleic acids research 50 (9), e53-e53, 2022 | 43 | 2022 |
| Distal phenylalanine modification for enhancing cellular delivery of fluorophores, proteins and quantum dots by cell penetrating peptides EJ Sayers, K Cleal, NG Eissa, P Watson, AT Jones Journal of controlled release 195, 55-62, 2014 | 43 | 2014 |
| Catastrophic endgames: emerging mechanisms of telomere-driven genomic instability K Cleal, DM Baird Trends in Genetics 36 (5), 347-359, 2020 | 37 | 2020 |
| DNA Ligase 1 is an essential mediator of sister chromatid telomere fusions in G2 cell cycle phase K Liddiard, B Ruis, Y Kan, K Cleal, KE Ashelford, EA Hendrickson, ... Nucleic acids research 47 (5), 2402-2424, 2019 | 28 | 2019 |
| High-throughput STELA provides a rapid test for the diagnosis of telomere biology disorders K Norris, AJ Walne, MJ Ponsford, K Cleal, JW Grimstead, A Ellison, ... Human genetics 140, 945-955, 2021 | 27 | 2021 |
| POLQ suppresses genome instability and alterations in DNA repeat tract lengths K Liddiard, AN Aston-Evans, K Cleal, EA Hendrickson, DM Baird NAR cancer 4 (3), zcac020, 2022 | 10 | 2022 |
| Telomere fusions associate with coding sequence and copy number alterations in CLL L Escudero, K Cleal, K Ashelford, C Fegan, C Pepper, K Liddiard, ... Leukemia 33 (8), 2093-2097, 2019 | 10 | 2019 |
| ATRX modulates the escape from a telomere crisis HEB Geiller, A Harvey, RE Jones, JW Grimstead, K Cleal, ... PLoS genetics 18 (11), e1010485, 2022 | 9 | 2022 |
| Tracking telomere fusions through crisis reveals conflict between DNA transcription and the DNA damage response K Liddiard, JW Grimstead, K Cleal, A Evans, DM Baird NAR cancer 3 (1), zcaa044, 2021 | 5 | 2021 |
| GW: ultra-fast chromosome-scale visualisation of genomics data K Cleal, A Kearsey, DM Baird bioRxiv, 2024.07. 26.605272, 2024 | | 2024 |
| O019 Studying telomere biology and genomic instability in gliomas H Bhatt, K Norris, K Cleal, K Kurian, W Gray, D Baird British Journal of Surgery 110 (Supplement_3), znad101. 019, 2023 | | 2023 |
| Investigating the impact of telomere dysfunction on the cancer genome L Escudero, C Fegan, C Pepper, K Ashelford, K Norris, K Cleal, K Liddiard, ... European Journal of Cancer 61, S11, 2016 | | 2016 |
| Exploring the use of Quantum dots as quantitative model delivery agents for small molecules, peptides and proteins K Cleal Cardiff University, 2015 | | 2015 |
| POLQ suppresses genome instability and DNA repeat expansions K Liddiard, AN Aston-Evans, K Cleal, EA Hendrickson, DM Baird | | |
